Full Press Release Details
SOUTH PLAINFIELD, N.J. , Sept. 27, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today announced that management will present a company update at the following conferences:
Cantor Global Healthcare Conference Friday, October 4 th at 10:40 a.m. ET
Chardan Genetic Medicines Conference Monday, October 7 th at 9:00 a.m. ET
The presentations will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com and will be archived for 2 weeks following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection. PTC's current Investor Presentation is available at the same website location.
About PTC Therapeutics, Inc. PTC is a science-led, global biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.
| FOR MORE INFORMATION PLEASE CONTACT: | |
| Media: | Investors: |
| Jane Baj | Emily Hill |
| +1 (908) 912-9167 | +1 (908) 912-9327 |
| [email protected] | [email protected] |
SOURCE PTC Therapeutics, Inc.